0.03265
-0.00335 (-9.31%)
-0.00335 (-9.31%)
Upgrade to Real-Time
Market Closed
| Volume | 1,496,536 |
|
|||||
| News | - | ||||||
| Day High | 0.036 | Low High |
|||||
| Day Low | 0.0307 | ||||||
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.00335 | -9.31% | 0.03265 | 13:15:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.036 | 0.0307 | 0.036 | 0.036 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 58 | 1,496,536 | $ 0.032257 | $ 48,274 | - | 0.0307 - 0.0924 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:46:44 | 1,000 | $ 0.03265 | USD |
Period:
Draw Mode:
Elite Pharmaceuticals Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 33.02M | 1.01B | 750.39M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 12.25k | $ - | - | - | - |
Elite Pharmaceuticals (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.03717 | 0.04 | 0.0307 | 0.0357236 | 1,031,195 | -0.00452 | -12.16% |
| 1 Month | 0.038 | 0.042 | 0.0307 | 0.0378935 | 802,379 | -0.00535 | -14.08% |
| 3 Months | 0.045 | 0.0489 | 0.0307 | 0.0411598 | 821,565 | -0.01235 | -27.44% |
| 6 Months | 0.05657 | 0.06 | 0.0307 | 0.0462002 | 847,287 | -0.02392 | -42.28% |
| 1 Year | 0.055 | 0.0924 | 0.0307 | 0.0546536 | 1,049,886 | -0.02235 | -40.64% |
| 3 Years | 0.07875 | 0.141 | 0.0307 | 0.0698527 | 877,833 | -0.0461 | -58.54% |
| 5 Years | 0.139 | 0.2495 | 0.0307 | 0.0920536 | 885,381 | -0.10635 | -76.51% |
Elite Pharmaceuticals (QB) Description
| Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, TAGI Pharma, and Glenmark Pharmaceuticals, Inc. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. |
